The regulatory framework for genetically modified organisms (GMOs) is horizontally fractured. Implementation of regulations has been delegated from agencies to manufacturers to producers. Developing and developed nations have different GMO concerns, as shown by the interaction of international treaties with the member state’s own priorities. As a result of the regulatory fragmentation, private parties play a role in the regulation through contracts, patents, and litigation.
Read original article

